AOTI

AOTI is a medical technology company focused on advanced wound care solutions. The company develops and markets non invasive therapeutic devices designed to improve outcomes for patients with chronic wounds, such as diabetic foot ulcers and venous leg ulcers. Their core technology leverages topical oxygen therapy to support healing in clinical settings and in home care environments.

Operating from a product portfolio backed by clinical evidence, AOTI positions itself as a specialized player in the wound care market, competing alongside larger medical device firms. The company’s main offering, the “TWO2” device, delivers continuous topical oxygen and has been adopted by wound care centers, hospitals, and home health agencies. AOTI appears to emphasize direct commercial outreach to healthcare providers as a key growth strategy.

Based on its current hiring for a Territory Sales Manager in one U.S. city, AOTI seems to be expanding its field sales force to build relationships with clinicians and healthcare systems. The focus on a single sales territory suggests a targeted, regional expansion approach rather than a broad national rollout. The company likely values candidates with experience in medical device sales, wound care, or capital equipment sales, and it appears to operate with a lean, results oriented structure typical of growth stage medtech firms.